Bio-Techne Corporation (NASDAQ: TECH) announced leadership changes, with Dr. Matt McManus stepping down as President of the Diagnostics and Spatial Biology Segment, effective March 1, 2026. Steve Crouse, currently Senior Vice President of Analytical Solutions, will succeed him. This transition aims to leverage Crouse’s extensive experience to drive the company’s next phase of growth alongside President of Protein Sciences, Will Geist.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Bio-Techne Announces Changes to its Leadership Team
Bio-Techne Corporation (NASDAQ: TECH) announced leadership changes, with Dr. Matt McManus stepping down as President of the Diagnostics and Spatial Biology Segment, effective March 1, 2026. Steve Crouse, currently Senior Vice President of Analytical Solutions, will succeed him. This transition aims to leverage Crouse’s extensive experience to drive the company’s next phase of growth alongside President of Protein Sciences, Will Geist.